January 2025 in “International Journal of Trichology” This study found that patients with androgenetic alopecia had significantly higher COVID-19 severity compared to matched controls, suggesting a potential link between androgen pathways and disease severity. The authors suggest further research to validate this hypothesis and explore antiandrogen treatments for managing COVID-19 severity.
September 2024 in “Journal of Cutaneous and Aesthetic Surgery” This case report detailed a successful treatment involving contracture release and expanded neck flap reconstruction for a patient with severe neck contracture and beard alopecia from past thermal burns, highlighting improved skin quality and hair regrowth following follicular unit extraction.
June 2024 in “International Journal of Research in Dermatology” This study found that combination therapy with PRP and minoxidil led to more significant improvement in androgenetic alopecia than either treatment alone, as confirmed by trichoscopic analysis.
May 2024 in “Indian journal of pharmacy and pharmacology” This in-vitro study reported that a luliconazole-based formulation improved hair cuticle integrity and was more effective than ketoconazole in repairing damaged hair after 5 and 10 washes, with sensory analysis supporting these results. Further human studies are needed to confirm its clinical effects.
January 2024 in “International Journal of Dermatology Research” This randomized clinical trial found that both topical ethinylestradiol 0.01% combined with minoxidil 2% and minoxidil 2% alone were similarly effective in enhancing hair growth for female pattern hair loss, though minoxidil alone was better tolerated with fewer side effects over 24 weeks.
December 2023 in “Pakistan Journal of Medical & Health Sciences” This study found that in South Asian women with PCOS, the severity of non-alcoholic fatty liver disease is strongly linked to early renal dysfunction, as indicated by increased serum creatinine and urinary albumin levels, and reduced eGFR.
December 2023 in “International Journal of Research in Dermatology” This study evaluated hormonal differences in males with early androgenetic alopecia, finding increased serum testosterone, prolactin, LH, LH/FSH, and FAI levels, with decreased FSH and SHBG levels, compared to controls without hair loss.
May 2023 in “Photobiomodulation, photomedicine, and laser surgery” In this study, 675 nm laser treatment significantly improved hair density and reduced miniaturization in both male and female patients with alopecia androgenetica, showing promising results without side effects after 10 sessions.
April 2023 in “Journal of Cutaneous and Aesthetic Surgery” In this study, researchers analyzed the occipital donor area for hair transplantation among men aged 50–55 with androgenetic alopecia and found that while most subjects met standard safe donor area criteria, individual variations suggest a conservative approach to donor area selection.
October 2022 in “Hair Transplantation” This review describes the evolution and categorization of FUE punch designs in hair restoration, noting the need for updated classifications to include new systems, but reports no new experimental findings.
July 2021 in “International journal of dermatology, venereology and leprosy sciences” This study found that diphenylcyclopropenone (DPCP) was more effective and better tolerated than dinitrochlorobenzene (DNCB) in promoting hair regrowth in patients with alopecia areata.
June 2021 in “Research Square (Research Square)” This study reports that a single injection of stromal vascular fraction (SVF) cells into the scalp of patients with androgenetic alopecia significantly increased hair density and thickness within 3 to 6 months, with no observed side effects.
April 2021 in “International Journal of Research in Dermatology” This study found that hormonal abnormalities are not very common in adult females with acne, although some patients showed indicators of hyperandrogenism.
In this study, significant hair loss was found to be less common among white male CEOs aged 50-69 years than in the general white male population.
January 2021 in “Skinmed” This study found that significant hair loss among white male CEOs aged 50-69 years occurred less frequently than previously reported for the general white male population.
October 2020 in “International Journal of Research in Dermatology” In this study, adding platelet-rich plasma to minoxidil and finasteride treatment for patterned hair loss improved hair outcomes with minimal side effects compared to using minoxidil and finasteride alone.
July 2020 in “Experimental Dermatology” This discussion of age-related changes in female scalp hair follicles reports no new results, highlighting the structural transformations that may contribute to thinning hair in women as they age.
April 2019 in “The Journal of urology/The journal of urology” After the FDA's 2011 warning about a potential prostate cancer risk with 5-alpha reductase inhibitors, this study observed a significant decrease in their prescriptions, notably a 49% drop among men with benign prostatic hyperplasia, while primary care providers reduced prescriptions by 60%.
March 2018 in “International journal of basic and clinical pharmacology” This study found that while the carboplatin-paclitaxel regimen for advanced lung cancer is more affordable than newer treatments and maintains a good performance status, it significantly increases risks of alopecia and peripheral neuropathy.
November 2017 in “Journal of Surgical Academia” This case report describes a woman with systemic lupus erythematosus who developed non-progressive visual field defects after hypertensive retinopathy, with cotton wool spots indicating retinal nerve fiber microinfarctions.
September 2017 in “Journal of Investigative Dermatology” In this study, a topical combination of Stemoxydine® and Resveratrol significantly increased hair density in women with female pattern hair loss after 12 weeks of use.
July 2016 in “American Journal of Dermatopathology” The meeting showcased rare skin disease cases, highlighting the need for accurate diagnosis and treatment.
April 2016 in “Journal of The American Academy of Dermatology” Daylight photodynamic therapy is effective and well-tolerated for treating actinic keratoses with minimal side effects.
November 2015 in “International journal of science and research” This study found that adult acne is more inflammatory than adolescent acne and predominantly affects the cheeks, jaw-line, and chin.
September 2013 in “Cancer Discovery” Finasteride is safe for long-term use in prostate cancer treatment.
November 2011 in “InTech eBooks” This study found no association between circulating androgens and prostate cancer risk, underscoring the complex role of androgen metabolism in the prostate.
August 2011 in “Der Urologe” This review discusses the impact of various treatments for prostate cancer, noting that while 5α-reductase inhibitors reduce risk, they may not decrease and could even increase high-risk cancers; the authors highlight that recent data suggest longer screening can reduce prostate cancer mortality more effectively.
July 2010 in “学術講演梗概集. A-1, 材料施工” This study found that in Taiwanese men with androgenetic alopecia, finasteride 1 mg/day over 1 year slowed hair loss and promoted hair growth, with minimal adverse effects.
Dutasteride reduces prostate cancer risk by 23% in high-risk men.
September 2009 in “European Urology Supplements” This study found that a 3 mm margin around the prostate CTV may be adequate if accompanied by frequent imaging, but superior-inferior displacements were notably greater than in other directions.